TITLE:
Subcutaneous Amifostine (Ethyol) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

CONDITION:
Esophagitis

INTERVENTION:
Amifostine

SUMMARY:

      The primary objective of this study is to assess the activity of subcutaneous (SC)
      amifostine on the incidence and severity of acute radiochemotherapy-induced esophagitis in
      patients with unresectable Stage IIIA or IIIB non-small cell lung cancer (NSCLC) receiving
      combined modality therapy.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        You may be eligible for this study if you are 18 years of age or older and:

          -  Have UnResectable Stage IIIA or IIIB Non Small Cell Lung Cancer

          -  Have never had prior chemotherapy with Paclitaxel or Carboplatin

          -  Have never had prior thoracic radiation therapy (XRT)
      
